Key result
In a rat model of renal ischaemia, PRR shRNA treatment significantly reduced the expression of inflammatory markers including TNF-α, COX-2, p-NF-κB, and MCP-1 (P<0.05) independent of blood pressure.
Why the study?
Does PRR shRNA reduce renal inflammation in a rat model of renal ischemia?
Does PRR shRNA reduce renal inflammation in a rat model of renal ischemia?
In a rat model of renal ischemia, the prorenin receptor mediates renal inflammation independently of blood pressure and Angiotensin II.
Should not change clinical practice; leaves open PRR as a therapeutic target in human renal ischemia.
We hypothesized that PRR contributes to renal inflammation in the 2-kidney, 1-clip (2K1C) renal ischaemia model. Male Sprague-Dawley rats were fed normal sodium diet. Blood pressure (BP) was obtained on days 0 and 28 after left renal artery clipping that reduced renal blood flow by 40%. Renal expression of TNF-α, COX-2, NF-κB, IL-1β, MCP-1 and collagen type I were assessed in sham and 2K1C rats with or without left renal administration of scramble or PRR shRNA. At baseline, there were no differences in BP. Compared to sham, MAP significantly increased in clipped animals (sham 102 ± 1.9 vs 2K1C 131.8 ± 3.09 mmHg, P < .05) and was not influenced by scramble or PRR shRNA treatment. Compared to sham and contra lateral (non-clipped) kidney, there was upregulation in mRNA and protein expression of PRR (99% and 45%, P < .01), TNF-α (72% and 50%, P < .05), COX-2 (72% and 39%, P < .05), p-NF-κB (92%, P < .05), MCP-1 (87%, P < .05) and immunostaining of collagen type I in the clipped kidney. These increases were not influenced by scramble shRNA. Compared to 2K1C and scramble shRNA, PRR shRNA treatment in the clipped kidney significantly reduced the expression of PRR (62% and 57%, P < .01), TNF-α (51% and 50%, P < .05), COX-2 (50% and 56%, P < .05), p-NF-κB by 68% (P < .05), MCP-1 by 73% (P < .05) and collagen type I respectively. Ang II was increased in both kidneys and did not change in response to scramble or PRR shRNA treatments. We conclude that PRR mediates renal inflammation in renal ischaemia independent of blood pressure and Ang II.
No takes yet. Share an insight, caveat, or question.
Quadri et al. (2017) studied Renal ischaemia. PRR shRNA vs. Scramble shRNA and sham was evaluated on Renal expression of inflammatory markers (TNF-α, COX-2, NF-κB, IL-1β, MCP-1) and collagen type I (p=< .05). In a rat model of renal ischaemia, PRR shRNA treatment significantly reduced the expression of inflammatory markers including TNF-α, COX-2, p-NF-κB, and MCP-1 (P<0.05) independent of blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: